SMTI
Sanara MedTech Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$33.14
−0.06%Year over year
Reported trailing growth
- Revenue
- +12.9%
- EBITDA
- +158.3%
- EBIT
- +783.2%
- EPS
- —
- Free cash flow
- +7544.7%
- Operating cash flow
- +56.1%
Forward estimates
Based on analyst estimates
- Revenue
- -13.9%
- EBITDA
- +20.5%
- EPS
- +111.5%
Three-year CAGR
- Revenue
- +31.0%
- EBITDA
- +1977.4%
- EBIT
- +236.2%
- Net income
- —
- EPS
- —
- Free cash flow
- +953.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026